TGFB1 and melanoma: Additionally, isoliquiritigenin was found to have an anti-tumor effect in melanoma [148] and anti-fibrotic effect in mesangial cells via inhibition of collagen, CTGF, and TGF-β1-smad signaling transduction [149].